Is silver the new gold?

Coca-Cola Co. is reportedly engaged in urgent discussions with TDR Capital this weekend as the sale of Costa Coffee is at risk of failing, according to the Financial Times. This situation highlights the challenges Coca-Cola faces in divesting its coffee brand amid potential market uncertainties.

Bank of America has indicated that gold prices, currently consolidating between $4,200 and $4,300, are more likely experiencing a temporary pause rather than hitting a ceiling. The price of gold has surged dramatically in 2025, rising from approximately $2,630 per ounce to around $4,282, marking an increase of about 63%.

Gold prices are poised for weekly gains as the market reacts positively to a dovish outlook from the Federal Reserve, which has led to increased investor interest in precious metals. Silver prices are also nearing record highs, reflecting strong demand and market sentiment.

Do Kwon, the founder of the cryptocurrencies Luna and TerraUSD, has been sentenced to 15 years in prison after pleading guilty to fraud. This sentence exceeds the time requested by prosecutors, reflecting the severity of the financial misconduct that led to a significant crash in 2022, resulting in substantial losses for investors.

The S&P 500 index closed at a record high, buoyed by a consumer-led rally that offset a decline in Oracle shares following disappointing earnings results. This marks a significant recovery for the index, reflecting investor confidence despite challenges in the tech sector.

The U.S. trade deficit narrowed to its lowest level in five years in September, primarily due to a reversal in gold imports as investors moved their stockpiled gold back overseas after initial fears of tariffs did not materialize. This shift reflects a significant change in trade dynamics, particularly in the precious metals market.

The complexities of quantum investing are gaining attention as the financial sector recognizes quantum computing as a potential frontier in technology. This emerging field is characterized by its intricate principles that challenge traditional investment strategies, suggesting a shift in how investors approach technology-driven markets.

The European Union has decided to shorten the exclusivity period for new drugs, allowing cheaper generics to enter the market a year earlier than previously allowed. This move aims to reduce healthcare costs and increase access to medications for patients across the EU.